What are the side effects of Jisanda/Bingtonsha? How do patients cope with discomfort during treatment?
Epclusa is an effective drug for the treatment of hepatitis C (HCV). Although it is effective, it may still cause some side effects. Most of the side effects of Gisanda are mild and short-lived, and usually do not require discontinuation of the drug. However, some patients may experience certain discomfort during treatment and should communicate with their doctor in time and take appropriate measures to alleviate it.
The most common side effects include headache, fatigue, nausea, diarrhea and insomnia. Most of these symptoms are mild reactions and usually appear in the early stages of treatment. Over time, these discomforts will be relieved as the patient gradually adapts to the drug. To reduce these side effects, there are some common countermeasures patients can take.
For example, nausea and vomiting can be reduced by eating lighter foods or eating at separate meals, and avoiding taking medication on an empty stomach may help relieve nausea symptoms. Headaches and fatigue can be improved by resting and maintaining good sleep habits. If the symptoms are severe, you can consult your doctor whether you need to adjust the drug dosage or take symptomatic treatment.
In addition, a small number of patients may experience abnormal liver function, manifested as elevated liver enzymes, etc. when using GIS3. For patients with a history of cirrhosis or other liver diseases, special attention needs to be paid to changes in liver function during treatment. If there are significant abnormalities in liver function, your doctor may recommend discontinuing the medication and conducting further evaluation.
In rare cases, GIS3 may cause more serious side effects, such as severe allergic reactions (such as rash, difficulty breathing, etc.). These symptoms are usually rare, but if they occur, you should stop taking the drug immediately and seek emergency treatment. For those patients who are allergic to this drug, this drug must be avoided and other suitable treatment options sought.
Reference: https://www.epclusa.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)